We supposed that SHED administration via the tail vein downregulated the serum levels of IL-1 and TNF-α and upregulated those of IL-10 in DN rats, not only improving insulin resistance but also affecting the renal immune response through inflammatory cytokines. This evidence concerns the gene TNF and Insulin resistance.